When promoting health and wellness, it often helps to use the popularity and power of monthly health awareness campaigns to instigate discussions, and, more importantly, promote mindfulness of public health issues.
Although, all too often, we only hear about the high prices of prescription products, I am excited about the degree of innovation and number of new drug approvals in our country.
- Passive Smoke Exposure Associated with Obesity, Poorer Cognition in Children
- Advocate Health Care to Own and Operate Retail Clinics at 56 Walgreens Locations
- FDA Approves 3 Oral Barium Sulfate Products for Adults and Pediatric Patients
- Link Exists Between Off-Patent Drug Price Increases and Shortages
- The Little Clinic Celebrates Reaching 4 Million Patient Visits Milestone
Irritable bowel syndrome (IBS) is the most frequent diagnosis in gastroenterology and primary care practices; however, there are few treatment options for patients with IBS with diarrhea.
Nutrition is an essential part of health and wellness. Approximately 117 million people in the United States have ≥1 preventable chronic diseases, which may be attributed to poor nutrition and physical inactivity.
Patients with uncontrolled asthma should be aware that asthma attacks can occur when they are exposed to certain asthma triggers. Because these triggers can vary from one person to the next, it is beneficial for patients with asthma to know their asthma triggers, and learn ways to avoid them.
Heart disease is the leading cause of death in men and women in the United States, accounting for 1 in 4 deaths. Take an opportunity in February to promote American Heart Month, and discuss how to prevent this condition.
At the 2015 Diagnostic Error in Medicine International Conference, a panel of experts made it clear in a discussion that there are many subtleties in mitigating liability for diagnostic errors in clinical practice.
- Methadone Ingestion
- High Blood Glucose Blamed for Stroke
- Failure to Assess Risk of Suicide
Although treatment options exist, patients with pulmonary arterial hypertension have a poor prognosis. Current recommendations include combination therapies that target the endothelin, nitric oxide, and prostacyclin pathways. The burden and risks of the administration of intravenous prostacyclin therapy likely contribute to the many patients who die before receiving this treatment.